Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!
Diabetes Care · 2023
DOI: 10.2337/dci23-0027 ↗Kurz gefasst
Editorial in der Zeitschrift Diabetes Care, 2023. Verfasst von Egeria Scoditti und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Institute of Clinical Physiology, National Research Council, Lecce, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Institute of Clinical Physiology, National Research Council, Lecce, Italy.
- 2Department of Medical and Surgical Sciences, Alma Mater University, Bologna, Italy.
- 3Azienda Ospedaliera di Bologna Sant'Orsola-Malpighi, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Bologna, Italy.
- 4Institute of Clinical Physiology, National Research Council, Pisa, Italy.
ORCID-Profile: Giulio Marchesini, Amalia Gastaldelli
Zitieren
APA
Scoditti, E., Marchesini, G., & Gastaldelli, A. (2023). Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!. Diabetes Care. https://doi.org/10.2337/dci23-0027
Vancouver
Scoditti E, Marchesini G, Gastaldelli A. Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!. Diabetes Care. 2023. doi:10.2337/dci23-0027
BibTeX
@article{Scoditti2023,
author = {Scoditti, Egeria and Marchesini, Giulio and Gastaldelli, Amalia},
title = {Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!},
journal = {Diabetes Care},
year = {2023},
doi = {10.2337/dci23-0027}
}
EUVIMED